Skip to main content

Matthew Hirschey

Associate Professor of Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
104775, Room 50-201, Durham, NC 27701
300 N. Duke Street, 50-201, Durham, NC 27701

Overview


The Hirschey Lab in the Duke Molecular Physiology Institute, and the Departments of Medicine and Pharmacology & Cancer Biology at Duke University studies different aspects of metabolic control, mitochondrial signaling, and cellular processes regulating human health and disease.

Current Appointments & Affiliations


Associate Professor of Medicine · 2019 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine
Associate Professor in Pharmacology and Cancer Biology · 2019 - Present Pharmacology & Cancer Biology, Basic Science Departments
Associate Professor of Cell Biology · 2022 - Present Cell Biology, Basic Science Departments
Member of Sarah W. Stedman Nutrition and Metabolism Center · 2011 - Present Sarah Stedman Nutrition & Metabolism Center, Duke Molecular Physiology Institute
Member of the Duke Cancer Institute · 2012 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published February 8, 2024
The AI Explosion, Explained
Published July 10, 2023
New University Course Offers a Technical and Ethical Exploration of Our Data-Centric World
Published May 12, 2023
Navigating AI at Duke

View All News

Recent Publications


Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia.

Journal Article bioRxiv · March 2, 2025 Understanding how cellular pathways interact is crucial for treating complex diseases like cancer, yet our ability to map these connections systematically remains limited. Individual gene-gene interaction studies have provided insights 1,2 , but they miss ... Full text Link to item Cite

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence.

Journal Article Sci Adv · April 5, 2024 Fewer than 20% of triple-negative breast cancer patients experience long-term responses to mainstay chemotherapy. Resistant tumor subpopulations use alternative metabolic pathways to escape therapy, survive, and eventually recur. Here, we show in vivo, lon ... Full text Link to item Cite
View All Publications

Recent Grants


Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029

Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Duke University Program in Environmental Health

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029

View All Grants

Education, Training & Certifications


University of California, Santa Barbara · 2006 Ph.D.